🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Pelvic Nerve Mobilization for Primary Dysmenorrhea

RecruitingNAAges 18 Years - 30 YearsFemaleUniversity of Hail
NCT07354451 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Primary dysmenorrhea is a highly prevalent condition among young women and is associated with significant pain, reduced quality of life, and academic absenteeism. Although non-steroidal anti-inflammatory drugs are commonly used, many women seek non-pharmacological alternatives due to limited effectiveness or adverse effects. Emerging evidence suggests that altered pelvic neurodynamics may contribute to dysmenorrheic pain. This randomized controlled trial aims to evaluate the effectiveness of external pelvic nerve mobilization in reducing menstrual pain and associated symptoms among university women with primary dysmenorrhea. Participants aged 18-30 years will be randomly allocated to receive either external pelvic nerve mobilization or a sham manual therapy intervention across three consecutive menstrual cycles. Outcomes will include pain intensity, menstrual distress, quality of life,

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Female university students aged 18-30 years * Regular menstrual cycles (24-35 days) * Clinically diagnosed primary dysmenorrhea * Average menstrual pain intensity ≥ 5 on Visual Analog Scale * Willingness to participate and provide informed consent Exclusion Criteria: * Secondary dysmenorrhea (e.g., endometriosis, fibroids, pelvic inflammatory disease) * History of pelvic or spinal surgery * Neurological disorders * Current pregnancy or lactation * Current physiotherapy or manual therapy treatment * Contraindications to manual therapy
💊

What it tests

  • External Pelvic Nerve Mobilization
  • Sham Mobilization
📍

Where

1 site
International Institute of Science Arts and Technology
Sialkot, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy